These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3761464)

  • 1. Effectiveness of antiandrogens in the rat.
    Burton S; Trachtenberg J
    J Urol; 1986 Oct; 136(4):932-5. PubMed ID: 3761464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative effectiveness of alternative androgen withdrawal therapies in initiating regression of rat prostate.
    Rennie PS; Bruchovsky N; Goldenberg SL; Lawson D; Fletcher T; Foekens JA
    J Urol; 1988 Jun; 139(6):1337-42. PubMed ID: 2967378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of steroidal and non-steroidal antiandrogens on the androgen binding properties of the rat ventral prostate androgen receptor.
    Steinsapir J; Mora G; Muldoon TG
    Biochim Biophys Acta; 1991 Aug; 1094(1):103-12. PubMed ID: 1883848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cyproterone acetate in comparison to flutamide and megestrol acetate on the ventral prostate, seminal vesicle, and adrenal glands of adult male rats.
    el Etreby MF; Habenicht UF; Louton T; Nishino Y; Schröder HG
    Prostate; 1987; 11(4):361-75. PubMed ID: 2960960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vinclozolin and p,p'-DDE alter androgen-dependent gene expression: in vivo confirmation of an androgen receptor-mediated mechanism.
    Kelce WR; Lambright CR; Gray LE; Roberts KP
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):192-200. PubMed ID: 9007049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of a 5-day Hershberger assay utilizing mature male rats and a pubertal male assay for detection of flutamide's antiandrogenic activity.
    Yamada T; Kunimatsu T; Sako H; Yabushita S; Sukata T; Okuno Y; Matsuo M
    Toxicol Sci; 2000 Feb; 53(2):289-96. PubMed ID: 10696777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the androgenic activity of synthetic "progestins" currently used for the treatment of prostate cancer.
    Labrie C; Cusan L; Plante M; Lapointe S; Labrie F
    J Steroid Biochem; 1987 Oct; 28(4):379-84. PubMed ID: 2444770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential androgen blockade: a biological study in the inhibition of prostatic growth.
    Fleshner NE; Trachtenberg J
    J Urol; 1992 Dec; 148(6):1928-31. PubMed ID: 1331549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ICI 176,334: a novel non-steroidal, peripherally-selective antiandrogen.
    Furr BJ
    Prog Clin Biol Res; 1988; 260():13-26. PubMed ID: 2966405
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological profile of RU 58642, a potent systemic antiandrogen for the treatment of androgen-dependent disorders.
    Battmann T; Branche C; Bouchoux F; Cerede E; Philibert D; Goubet F; Teutsch G; Gaillard-Kelly M
    J Steroid Biochem Mol Biol; 1998 Jan; 64(1-2):103-11. PubMed ID: 9569015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the accelerative effects of testosterone on hamster facial nerve regeneration by the antiandrogen flutamide.
    Kujawa KA; Tanzer L; Jones KJ
    Exp Neurol; 1995 Jun; 133(2):138-43. PubMed ID: 7649220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the expression of protein kinase C isoenzymes in rat ventral prostate: effects of age, castration and flutamide treatment.
    Montalvo L; Sánchez-Chapado M; Prieto JC; Carmena MJ
    Life Sci; 2002 Sep; 71(19):2257-66. PubMed ID: 12215373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiandrogenic drugs.
    McLeod DG
    Cancer; 1993 Feb; 71(3 Suppl):1046-9. PubMed ID: 8428326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daily dosing with flutamide or Casodex exerts maximal antiandrogenic activity.
    Luo S; Martel C; Chen C; Labrie C; Candas B; Singh SM; Labrie F
    Urology; 1997 Dec; 50(6):913-9. PubMed ID: 9426723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of anti-androgenic activity of flutamide, vinclozolin, procymidone, linuron, and p, p'-DDE in rodent 10-day Hershberger assay.
    Kang IH; Kim HS; Shin JH; Kim TS; Moon HJ; Kim IY; Choi KS; Kil KS; Park YI; Dong MS; Han SY
    Toxicology; 2004 Jul; 199(2-3):145-59. PubMed ID: 15147789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Castration levels of plasma testosterone have potent stimulatory effects on androgen-sensitive parameters in the rat prostate.
    Marchetti B; Poulin R; Plante M; Labrie F
    J Steroid Biochem; 1988 Oct; 31(4A):411-9. PubMed ID: 2845194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a nonsteroidal antiandrogen, anandron, on the reproductive system and fertility in male rats.
    Dhar JD; Setty BS
    Contraception; 1990 Jul; 42(1):121-38. PubMed ID: 2387152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiandrogens: a summary review of pharmacodynamic properties and tolerability in prostate cancer therapy.
    Migliari R; Muscas G; Murru M; Verdacchi T; De Benedetto G; De Angelis M
    Arch Ital Urol Androl; 1999 Dec; 71(5):293-302. PubMed ID: 10673793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of an antiandrogen, anandron, used as an adjuvant therapy in the treatment of prostate cancer.
    Moguilewsky M; Fiet J; Tournemine C; Raynaud JP
    J Steroid Biochem; 1986 Jan; 24(1):139-46. PubMed ID: 3009970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICI 176,334: a novel non-steroidal, peripherally selective antiandrogen.
    Furr BJ; Valcaccia B; Curry B; Woodburn JR; Chesterson G; Tucker H
    J Endocrinol; 1987 Jun; 113(3):R7-9. PubMed ID: 3625091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.